The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
about
Mast cell stabilisers for seasonal and perennial allergic conjunctivitisOral antihistamines for seasonal allergic conjunctivitisMast cell stabilisers for seasonal and perennial allergic conjunctivitisSublingual immunotherapy for treating allergic conjunctivitisInter-Relationship between Rhinitis and Conjunctivitis in Allergic Rhinoconjunctivitis and Associated Risk Factors in Rural UK ChildrenClimate change effect on Betula (birch) and Quercus (oak) pollen seasons in the United StatesBayesian Analysis of Climate Change Effects on Observed and Projected Airborne Levels of Birch PollenAtopy and Specific Cancer Sites: a Review of Epidemiological Studies.Surveillance Tools Emerging From Search Engines and Social Media Data for Determining Eye Disease Patterns.Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitisOcular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.Allergic conjunctivitis and the most common allergens in Northern GreeceRecent patents and emerging therapeutics in the treatment of allergic conjunctivitis.Allergic diseases in the elderlyPossible Mechanism of Action of the Antiallergic Effect of an Aqueous Extract of Heliotropium indicum L. in Ovalbumin-Induced Allergic ConjunctivitisExacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergyTGFβ receptor mutations impose a strong predisposition for human allergic diseaseThe association between asthma and allergic disease and mortality: a 30-year follow-up study.Alcaftadine for the prevention of itching associated with allergic conjunctivitis.Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.Emerging therapies in allergic conjunctivitis and dry eye syndrome.Bepotastine besilate for the treatment of pruritus.Investigational drugs for the treatment of allergic rhinitis.Advances in pharmacotherapy for allergic conjunctivitis.Pathogenesis of rhinitis.Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief.Allergen immunotherapy: an updated review of safety.Allergic conjunctivitis: a cross-sectional study.The anatomical and functional relationship between allergic conjunctivitis and allergic rhinitisEfficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment.Determination of seasonal allergic conjunctivitis variation using internet search engine data.Differences in sleep quality and health-related quality of life in young adults with allergies and asthma and their healthy peers.Lacrimal gland lesions in Denmark between 1974 and 2007.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Association between allergic rhinitis and nasopharyngeal carcinoma: a population-based study.Ocular allergy.Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.Google unveils a glimpse of allergic rhinitis in the real world.Denervation of nasal mucosa induced by posterior nasal neurectomy suppresses nasal secretion, not hypersensitivity, in an allergic rhinitis rat model.Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis.
P2860
Q24188328-3C838FB1-0BAE-4449-925D-79025A268F33Q24194291-AE9FA92A-EA70-44E1-AE0C-D677C7CB0458Q24202609-535420AA-3385-4281-B9A5-BFC1337359A3Q24235657-0C9E6471-B07B-4A47-906C-88F9FD02513EQ27339408-4CBB23BB-235B-4CFC-9D6D-6B5185DAC418Q28392288-07622819-FA3B-4AF4-86F7-3B65D051543EQ28395883-2AFE900F-6E0C-4132-B58B-0EEB2B0876FDQ30249752-F88859BD-04DC-4E24-BF3F-55A269AE7379Q31114704-71D815E0-98BC-494F-99CA-AF424F2814DEQ33803658-DC88DB1B-84CA-4294-B0BE-296DE75EC3D5Q34402420-C6720165-551D-45C9-B12A-DE359A0C5CF0Q34834635-A937D104-1BE6-4EAA-AD23-8C5F63545154Q35187578-3182E1B5-3D79-477A-9523-67B4C2587985Q35919934-94F58F1C-87AE-445A-8FF7-2A761A1A245DQ36310301-EF6EAA8A-70C6-40E3-AA38-4D19386EB583Q36558238-EB70823D-6FB9-4458-ABC6-E27AB2F016F6Q37526777-BF55686A-0ADB-45FF-8036-DF3B723D5F8DQ37735101-AC96824B-1868-4405-9BC3-6718A343E245Q38027464-2E38A98C-BAEE-439A-811A-EC099FAFB047Q38040514-8963FA26-5BA1-4FD3-B8C4-1A6D4AABC0FAQ38119024-24A6812D-D392-4AE5-A2C6-D70E49FE7A02Q38160064-3A1649C9-EDDD-450B-B57C-F08A531FF670Q38202695-340498A9-842E-4029-A79E-AAF9ADC4E7A0Q38460976-17B9FD47-D732-450A-A769-E9FE8F01C056Q38902173-FCE4666F-FD94-4DEA-9B28-C8E701EC105AQ38910692-6F2F61BB-6B61-4EF1-9CFC-006F6B0B4584Q39025721-554FBD28-E0E2-44E0-9CD4-8C3097C5EA31Q41158878-DA6BAAB7-AB97-4EBC-9EDC-1051063CEB8AQ41909205-2F7B27AD-42A8-4964-B423-732B1AB5C678Q42280478-7CDC8D34-D11C-485C-BBA9-6B17E9A48D16Q43007305-EBF6E167-68F3-463C-9B90-6BF769724A47Q44612214-57A1E53E-50D0-43DC-8E59-890EE8C156C5Q46458539-0F69C633-A9E1-4CDD-AA62-7883FDCAD164Q47764778-2DB3230C-792D-4459-A746-1C86BB6D5649Q48141799-4BBA2F24-AD77-425C-A1E4-66AA8B9FC1ACQ50526330-235CD1D0-7BCD-42F0-B601-9566DE9F7361Q50540256-8C523C4A-ED59-42CE-B21F-057301986D95Q51455718-56B46946-D1F4-4084-9F2D-3E0CCC518942Q51504430-26125864-F5AB-4B20-8032-1C1F789A6184Q55365208-11585958-1138-464C-AA73-384E283EEEBC
P2860
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@ast
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@en
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@nl
type
label
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@ast
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@en
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@nl
prefLabel
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@ast
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@en
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@nl
P2093
P1476
The epidemiology of ocular and nasal allergy in the United States, 1988-1994.
@en
P2093
Kavita Singh
Leonard Bielory
Sara Axelrod
P304
778-783.e6
P356
10.1016/J.JACI.2010.06.050
P407
P577
2010-10-01T00:00:00Z